The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fiorelli, V.
Right arrow Articles by Ensoli, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fiorelli, V.
Right arrow Articles by Ensoli, B.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*AIDS
*Kaposi's Sarcoma
The Journal of Immunology, 1999, 162: 1165-1170.
Copyright © 1999 by The American Association of Immunologists

IFN-{gamma} Induces Endothelial Cells to Proliferate and to Invade the Extracellular Matrix in Response to the HIV-1 Tat Protein: Implications for AIDS-Kaposi’s Sarcoma Pathogenesis1

Valeria Fiorelli*, Giovanni Barillari{dagger}, Elena Toschi{dagger}, Cecilia Sgadari{dagger}, Paolo Monini{dagger}, Michael Stürzl{ddagger} and Barbara Ensoli2,{dagger}

* Department of Allergy and Clinical Immunology, University of Rome "La Sapienza," Rome, Italy; {dagger} Laboratory of Virology, Istituto Superiore di Sanità, Rome, Italy; and {ddagger} Gesellschaft für Strahlung und Umweltforschung (GSF)-National Research Center for Environment and Health, Institute of Molecular Virology, Neuherberg and Technical University of Munich, Institute of Virology, Munich, Germany

Previous studies indicated that the Tat protein of HIV functions as a progression factor in Kaposi’s sarcoma (KS), an angioproliferative disease common and aggressive in HIV-1-infected individuals (AIDS-KS). In particular, Tat that is released by infected cells stimulates the growth and invasion of spindle cells of endothelial origin derived from KS lesions (KS cells). Other work suggested that inflammatory cytokines may act as initiating factors in KS since they induce normal endothelial cells to acquire the same phenotype and functional features of KS cells, including the responsiveness to Tat. In this study, we show that among the inflammatory cytokines increased in AIDS-KS lesions, IFN-{gamma} alone is sufficient to induce endothelial cells to proliferate and to invade the extracellular matrix in response to Tat. This is because IFN-{gamma} up-regulates the expression and activity of the receptors for Tat identified as the integrins {alpha}5ß1 and {alpha}vß3. These results suggest that, by triggering Tat effects, IFN-{gamma} plays a major role in AIDS-KS pathogenesis.




This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
E. Toschi, I. Bacigalupo, R. Strippoli, C. Chiozzini, A. Cereseto, M. Falchi, F. Nappi, C. Sgadari, G. Barillari, F. Mainiero, et al.
HIV-1 Tat Regulates Endothelial Cell Cycle Progression via Activation of the Ras/ERK MAPK Signaling Pathway
Mol. Biol. Cell, April 1, 2006; 17(4): 1985 - 1994.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Urbinati, A. Bugatti, M. Giacca, D. Schlaepfer, M. Presta, and M. Rusnati
{alpha}v{beta}3-integrin-dependent activation of focal adhesion kinase mediates NF-{kappa}B activation and motogenic activity by HIV-1 Tat in endothelial cells
J. Cell Sci., September 1, 2005; 118(17): 3949 - 3958.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Milligan, M. Robinson, E. O'Donnell, and D. J. Blackbourn
Inflammatory Cytokines Inhibit Kaposi's Sarcoma-Associated Herpesvirus Lytic Gene Transcription in In Vitro-Infected Endothelial Cells
J. Virol., March 1, 2004; 78(5): 2591 - 2596.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
G. Barillari and B. Ensoli
Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma
Clin. Microbiol. Rev., April 1, 2002; 15(2): 310 - 326.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
E. Toschi, G. Barillari, C. Sgadari, I. Bacigalupo, A. Cereseto, D. Carlei, C. Palladino, C. Zietz, P. Leone, M. Sturzl, et al.
Activation of Matrix-Metalloproteinase-2 and Membrane-Type-1-Matrix-Metalloproteinase in Endothelial Cells and Induction of Vascular Permeability In Vivo by Human Immunodeficiency Virus-1 Tat Protein and Basic Fibroblast Growth Factor
Mol. Biol. Cell, October 1, 2001; 12(10): 2934 - 2946.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Sgadari, E. Toschi, C. Palladino, G. Barillari, D. Carlei, A. Cereseto, C. Ciccolella, R. Yarchoan, P. Monini, M. Sturzl, et al.
Mechanism of Paclitaxel Activity in Kaposi's Sarcoma
J. Immunol., July 1, 2000; 165(1): 509 - 517.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. Weiss and C. Boshoff
Addressing Controversies Over Kaposi's Sarcoma
J Natl Cancer Inst, May 3, 2000; 92(9): 677 - 679.
[Full Text] [PDF]


Home page
J. Immunol.Home page
G. Barillari, C. Sgadari, C. Palladino, R. Gendelman, A. Caputo, C. B. Morris, B. C. Nair, P. Markham, A. Nel, M. Sturzl, et al.
Inflammatory Cytokines Synergize with the HIV-1 Tat Protein to Promote Angiogenesis and Kaposi's Sarcoma Via Induction of Basic Fibroblast Growth Factor and the {alpha}v{beta}3 Integrin
J. Immunol., August 15, 1999; 163(4): 1929 - 1935.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Barillari, C. Sgadari, V. Fiorelli, F. Samaniego, S. Colombini, V. Manzari, A. Modesti, B. C. Nair, A. Cafaro, M. Sturzl, et al.
The Tat Protein of Human Immunodeficiency Virus Type-1 Promotes Vascular Cell Growth and Locomotion by Engaging the alpha 5beta 1 and alpha vbeta 3 Integrins and by Mobilizing Sequestered Basic Fibroblast Growth Factor
Blood, July 15, 1999; 94(2): 663 - 672.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.